Allergy Therapeutics plc is looking to de-list in London – and then intends to join the public markets in Hong Kong. The West Sussex-based MedTech, led by CEO Manuel Llobet (pictured), has maintained a London listing since 2004 but its board has complained of costs amid a 71% drop in its share price this year. … Continue reading Allergy Therapeutics AIMs to go private… then list in Hong Kong